Want to see JP:4544 full AI Analyst Report?
4544 Stock Chart & Stats
¥3729.00
¥5.00(0.19%)
At close: 4:00 PM EST
¥3729.00
¥5.00(0.19%)
Day’s Range― - ―
52-Week Range¥2,944.50 - ¥4,093.00
Previous CloseN/A
Volume178.60K
Average Volume (3M)243.85K
Market Cap
¥193.47B
Enterprise Value¥203.34K
Total Cash (Recent Filing)¥48.10B
Total Debt (Recent Filing)¥74.33B
Price to Earnings (P/E)27.5
Beta0.27
Next Earnings
Aug 12, 2026EPS Estimate
16.44Next Dividend Ex-DateN/A
Dividend Yield3.72%
Share Statistics
EPS (TTM)123.02
Shares Outstanding57,493,220
10 Day Avg. Volume223,460
30 Day Avg. Volume243,853
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.30
Price to Sales (P/S)0.72
P/FCF Ratio9.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥3,820.00Price Target Upside2.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)97.72
Revenue Forecast (FY)¥256.69B
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationHUGroup has repeatedly generated positive operating and free cash flow, including through a loss year, and delivered ~¥19.2B FCF in FY2026. Durable cash generation supports reinvestment, debt reduction, and dividend capacity, providing financial flexibility over the next 2–6 months.
Manageable LeverageLeverage is moderate with debt-to-equity roughly 0.5–0.7 and falling total debt in FY2026. A solid equity base and declining indebtedness reduce refinancing risk and support capital allocation choices, strengthening balance-sheet resilience against cyclical pressures.
Stable Fee-for-service ModelHUGroup’s core fee-for-service diagnostics and specimen logistics model creates steady revenue tied to healthcare utilization. This structural demand from hospitals and clinics provides predictable volume drivers and durable service revenues less prone to short-term market swings.
Bears Say
Volatile ProfitabilityProfitability has been inconsistent: strong margins in FY2022–FY2023 gave way to a FY2024 loss and only modest recovery later. Persistent margin volatility undermines earnings predictability and could constrain reinvestment or dividend stability if structural pressures persist.
Significant Revenue DeclineA sharp FY2026 revenue drop of about 13.9% signals demand or mix headwinds beyond short-term noise. Sustained or recurring top-line weakness would pressure margins and cash flow, reducing the company's ability to fund growth initiatives or further deleveraging.
Free Cash Flow SensitivityAlthough FCF remains positive, recent swings and a sharp FY2026 drop indicate sensitivity to working capital, profitability swings, and investment timing. This volatility can complicate planning and raises execution risk for sustained capital return or strategic spending.
HUGroup Holdings News
4544 FAQ
What was HUGroup Holdings’s price range in the past 12 months?
HUGroup Holdings lowest stock price was ¥2944.50 and its highest was ¥4093.00 in the past 12 months.
What is HUGroup Holdings’s market cap?
HUGroup Holdings’s market cap is ¥193.47B.
When is HUGroup Holdings’s upcoming earnings report date?
HUGroup Holdings’s upcoming earnings report date is Aug 12, 2026 which is in 24 days.
How were HUGroup Holdings’s earnings last quarter?
HUGroup Holdings released its earnings results on May 14, 2026. The company reported ¥22.09 earnings per share for the quarter, beating the consensus estimate of ¥21.284 by ¥0.806.
Is HUGroup Holdings overvalued?
According to Wall Street analysts HUGroup Holdings’s price is currently Undervalued.
Does HUGroup Holdings pay dividends?
HUGroup Holdings pays a Semiannually dividend of ¥62 which represents an annual dividend yield of 3.72%. See more information on HUGroup Holdings dividends here
What is HUGroup Holdings’s EPS estimate?
HUGroup Holdings’s EPS estimate is 16.44.
How many shares outstanding does HUGroup Holdings have?
HUGroup Holdings has 57,493,220 shares outstanding.
What happened to HUGroup Holdings’s price movement after its last earnings report?
HUGroup Holdings reported an EPS of ¥22.09 in its last earnings report, beating expectations of ¥21.284. Following the earnings report the stock price went up 2.967%.
Which hedge fund is a major shareholder of HUGroup Holdings?
Currently, no hedge funds are holding shares in JP:4544
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HUGroup Holdings
Established in 1950 and headquartered in Tokyo, Japan, H.U. Group Holdings, Inc. (formerly Miraca Holdings Inc. until its rebranding in July 2020) provides an extensive array of laboratory testing products and services through its subsidiaries across Japan. The company delivers diagnostic testing and associated services to medical facilities, supports self-medication initiatives, and conducts testing for food, environmental samples, and cosmetic products. Additionally, it offers testing solutions tailored for corporate health insurance programs. The group is deeply involved in the research, development, manufacturing, and commercialization of in vitro diagnostic devices. Its product lineup features the LUMIPULSE, an automated chemiluminescent enzyme immunoassay system that supplies reagents for the detection of infectious diseases, various cancers, and lifestyle-related conditions to medical institutions and diagnostic centers. H.U. Group also produces the ESPRINE series of rapid diagnostic kits for ailments such as influenza, hepatitis B, and the novel coronavirus, alongside supplying essential ingredients for test drugs. Beyond diagnostics, the company offers crucial support services for hospital administration, including assistance during surgical and endoscope procedures, inspection and maintenance of medical equipment, and in-hospital logistics and transportation management. Furthermore, it addresses the elderly care market by renting and selling specialized equipment and supplies, and by providing in-home nursing care services.
4544 Stock 12 Month Forecast
Average Price Target
¥3,820.00
▲(2.44% Upside)
Technical Analysis
Ship Healthcare Holdings
―
Medley
―
Create SD Holdings Co., Ltd.
―
Solasto Corp.
―
Genky DrugStores Co., Ltd.
―







